US equities |
NVDA $238.58 ▲+1.98% SPCX $167.33 ▲+5.27% MU $1,062.94 ▼-1.11% TSLA $380.08 ▲+2.56% MSFT $525.74 ▲+1.59% SNDK $1,705.38 ▼-0.85% INTC $117.12 ▼-1.85% META $742.79 ▲+2.02%
FinancialContent

Invitro International (OP:IVRO)

0.0600 UNCHANGED
Delayed Quote Updated: 10:50 AM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Invitro International

News headline image
IVRO Continues Drive to Minimize Unnecessary Live Animal Testing
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
IVRO Continues Drive to Minimize Unnecessary Live Animal Testing
Via TheNewswire.com
News headline image
IVRO'S Mission To Help Make Non-Animal Testing Famous Now Searches For Strategic Partners
PLACENTIA, CA / ACCESSWIRE / September 1, 2021 / InVitro International (OTC PINK:IVRO) announced today that it has taken a first step in its search for strategic partners. IVRO entered into Letter of... 
From InVitro International
Via AccessWire
News headline image
IVRO Pursues Mission To "Help Make Non Animal Testing Famous"; Releases FY Q3 and YTD 2021 Results
PLACENTIA, CA / ACCESSWIRE / August 4, 2021 / InVitro International (OTC PINK:IVRO) is pleased to announce FY 2021 3rd quarter revenues of $310,700 and net income of $87,644. These sales were 35%+ vs... 
From InVitro International
Via AccessWire
Topics Animal Testing
News headline image
IVRO Continues Its Mission To "Help Make Non Animal Testing Famous"; Releases FY Q2 and YTD 2021 Results
PLACENTIA, CA / ACCESSWIRE / May 11, 2021 / InVitro International (OTC PINK:IVRO) today announced net income of $10,094 for its first six months of fiscal 2021 and a net loss of $57,704 in the 2nd... 
From InVitro International
Via AccessWire
Topics Animal Testing